Profund Advisors LLC Morphic Holding, Inc. Transaction History

Profund Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$26.12 - $34.07 $528,616 - $689,508	-20,238 Reduced 59.05%	14,033 $478,000
Q1 2024 May 08, 2024	BUY	$26.64 - $40.31 $36,976 - $55,950	1,388 Added 4.22%	34,271 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $185,834 - $288,765	9,315 Added 39.52%	32,883 $949,000
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $2,644 - $7,368	-124 Reduced 0.52%	23,568 $539,000
Q2 2023 Aug 10, 2023	BUY	$34.33 - $62.11 $429,777 - $777,555	12,519 Added 112.05%	23,692 $1.36 Million
Q1 2023 May 11, 2023	BUY	$26.01 - $48.69 $290,609 - $544,013	11,173 New	11,173 $420,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.